The current research program was designed to further our knowledge about the nature of schizophrenia by a prospective, longitudinal, investigation of the following questions about schizophrenic psychosis and schizophrenic cognition. 1) What is the longitudinal course of schizophrenic thought disorders? Are thought disorders primarily symptoms which persist when the patient is in the recovery phase? 2. What are the essential or primary features which are always present in schizophrenic thought disorders? What underlying factors influence schizophrenic thought disorders? 3. Can thought disorders and/or psychotic symptoms (such as first-rank symptoms, delusions or hallucinations) identify a nuclear or """"""""true"""""""" schizophrenic subgroup, with a very negative clinical course? 4. What is the long-term course of psychotic distortions (first-rank symptoms, delusions, etc.) and how important are they as characteristics of schizophrenia? 5. What is the longitudinal course of adjustment in modern-day schizophrenia? The research involves a multi-faceted longitudinal investigation of thought disorders, first-rank symptoms, and other psychotic symptoms, and major components of adjustment over time, using a battery of structured interviews, performance tests, cognitive measures, personality inventories and behavioral ratings. Two samples of schizophrenic and nonschizophrenic patients are being assessed at five time periods, lasting up to eleven years for one subsample. Patients are evaluated at the acute phase, during partial recovery, and followed up at various phases during the post-hospital period, for disordered thinking and psychotic symptoms. They also are assessed for neurotic and affective symptoms, rehospitalization, personality variables, and social and work adjustment. The data are used to evaluate a number of theories about prognostic factors, disordered cognition, and psychosis, and to assess the long-term clinical course and level of adjustment in modern day schizophrenia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH026341-11
Application #
3374959
Study Section
(PCBA)
Project Start
1977-01-01
Project End
1986-02-28
Budget Start
1985-03-01
Budget End
1986-02-28
Support Year
11
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Michael Reese Hosp & Medical Center (Chicago)
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60616
Harrow, M; Jobe, T H; Faull, R N (2014) Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study. Psychol Med 44:3007-16
Sarapas, Casey; Shankman, Stewart A; Harrow, Martin et al. (2013) Attention/processing speed prospectively predicts social impairment 18 years later in mood disorders. J Nerv Ment Dis 201:824-7
Goghari, V M; Harrow, M; Grossman, L S et al. (2013) A 20-year multi-follow-up of hallucinations in schizophrenia, other psychotic, and mood disorders. Psychol Med 43:1151-60
Harrow, Martin; Jobe, Thomas H (2013) Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery? Schizophr Bull 39:962-5
Sarapas, Casey; Shankman, Stewart A; Harrow, Martin et al. (2012) Parsing trait and state effects of depression severity on neurocognition: Evidence from a 26-year longitudinal study. J Abnorm Psychol 121:830-7
Kaplan, Kalman J; Harrow, Martin; Faull, Robert N (2012) Are there gender-specific risk factors for suicidal activity among patients with schizophrenia and depression? Suicide Life Threat Behav 42:614-27
Harrow, M; Jobe, T H; Faull, R N (2012) Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Psychol Med 42:2145-55
Goldberg, Joseph F; Harrow, Martin (2011) A 15-year prospective follow-up of bipolar affective disorders: comparisons with unipolar nonpsychotic depression. Bipolar Disord 13:155-63
Burdick, K E; Goldberg, J F; Harrow, M (2010) Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up. Acta Psychiatr Scand 122:499-506
Shankman, Stewart A; Nelson, Brady D; Harrow, Martin et al. (2010) Does physical anhedonia play a role in depression? A 20-year longitudinal study. J Affect Disord 120:170-6

Showing the most recent 10 out of 68 publications